Status report of lipid-lowering trials in diabetes

D. John Betteridge, Helen Colhoun, Jane Armitage

    Research output: Contribution to journalArticlepeer-review

    12 Citations (Scopus)


    The prevention and treatment of coronary heart disease is a major challenge in the overall management of the patient with type 2 diabetes. Diabetic dyslipidaemia is an important risk factor and is open to therapeutic intervention. However, as yet there are no primary or secondary coronary heart disease prevention trials of lipid-lowering therapy reported in diabetic populations. In this review, on-going clinical trials of lipid-lowering therapy in specific diabetic populations will be described.
    Original languageEnglish
    Pages (from-to)621-626
    Number of pages6
    JournalCurrent Opinion in Lipidology
    Issue number6
    Publication statusPublished - Dec 2000


    Dive into the research topics of 'Status report of lipid-lowering trials in diabetes'. Together they form a unique fingerprint.

    Cite this